文献速递糖尿病

近端与远端小肠葡萄糖暴露对血糖、肠促胰素分泌及肠促胰素效应的比较

Comparative Effects of Proximal and Distal Small Intestinal Glucose Exposure on Glycemia, Incretin Hormone Secretion, and the Incretin Effect in Health and Type 2 Diabetes.
PubMed 文献 · Diabetes Care · 2019-02-14

本研究在10名健康人和10名2型糖尿病患者中,通过鼻导管分别向近端(幽门后13 cm)和远端(190 cm)小肠输注30 g葡萄糖,并匹配等血糖钳夹,比较血糖、肠促胰素分泌及肠促胰素效应。结果显示近端输注后血糖更高,GLP-1升高轻微,而远端输注后GLP-1大幅升高,且远端输注的肠促胰素效应和GIGD更优。

要点

  • 远端小肠输注葡萄糖比近端输注更有效降低血糖。
  • 远端输注显著增加GLP-1分泌,近端输注则轻微。
  • 远端输注的肠促胰素效应和GIGD均优于近端。

核心结论

  • 在健康人和2型糖尿病患者中,远端小肠比近端小肠更优越地调节餐后葡萄糖代谢。

研究设计与样本

  • 研究纳入10名健康受试者和10名2型糖尿病患者,每人在四个场合接受研究。

主要发现

  • 近端和远端输注后血糖和3-O-甲基葡萄糖浓度均升高,但近端输注后更高(P < 0.001)。
  • 远端输注后血浆GLP-1大幅升高,而近端输注后仅轻微升高(P < 0.001)。
  • 近端和远端输注后GIP均迅速升高,近端初始浓度更高但持续时间更短(P < 0.001)。
  • 近端输注的肠促胰素效应和GIGD均低于远端输注(P ≤ 0.009)。

临床怎么用

  • 提示通过改变葡萄糖暴露的小肠区域可能影响肠促胰素效应和血糖控制。

局限性

  • 研究样本量较小(健康人和2型糖尿病患者各10例),结论需更大样本验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Cells releasing glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) are distributed predominately in the proximal and distal gut, respectively. Hence, the region of gut exposed to nutrients may influence GIP and GLP-1 secretion and impact on the incretin effect and gastrointestinal-mediated glucose disposal (GIGD). We evaluated glycemic and incretin responses to glucose administered into the proximal or distal small intestine and quantified the corresponding incretin effect and GIGD in health and type 2 diabetes mellitus (T2DM). RESEARCH DESIGN AND METHODS: Ten healthy subjects and 10 patients with T2DM were each studied on four occasions. On two days, a transnasal catheter was positioned with infusion ports opening 13 cm and 190 cm beyond the pylorus, and 30 g glucose with 3 g 3-O-methylglucose (a marker of glucose absorption) was infused into either site and 0.9% saline into the alternate site over 60 min. Matching intravenous isoglycemic clamp studies were performed on the other two days. Blood glucose, serum 3-O-methylglucose, and plasma hormones were evaluated over 180 min. RESULTS: In both groups, blood glucose and serum 3-O-methylglucose concentrations were higher after proximal than distal glucose infusion (all P < 0.001). Plasma GLP-1 increased minimally after proximal, but substantially after distal, glucose infusion, whereas GIP increased promptly after both infusions, with concentrations initially greater, but less sustained, with proximal versus distal infusion (all P < 0.001). Both the incretin effect and GIGD were less with proximal than distal glucose infusion (both P ≤ 0.009). CONCLUSIONS: The distal, as opposed to proximal, small intestine is superior in modulating postprandial glucose metabolism in both health and T2DM.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Zhang X, Young RL, Bound M, et al. Comparative Effects of Proximal and Distal Small Intestinal Glucose Exposure on Glycemia, Incretin Hormone Secretion, and the Incretin Effect in Health and Type 2 Diabetes. Diabetes Care. 2019. PMID: 30765429. doi:10.2337/dc18-2156

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。